Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint™ Knee Replacement System
August 18, 2021 17:00 ET
|
Conformis, Inc.
BILLERICA, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity Imprint knee replacement system. Identity...
Conformis Reports Second Quarter 2021 Financial Results
August 04, 2021 16:05 ET
|
Conformis, Inc.
BILLERICA, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Release Second Quarter 2021 Financial Results on August 4, 2021
July 01, 2021 17:00 ET
|
Conformis, Inc.
BILLERICA, Mass., July 01, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the second quarter ended June 30, 2021 after the...
Conformis, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
May 18, 2021 08:15 ET
|
Conformis, Inc.
BILLERICA, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. Announces 510(k) Clearance for Identity Imprint™ Knee Replacement System
May 10, 2021 07:30 ET
|
Conformis, Inc.
BILLERICA, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration for the Company’s Identity Imprint Knee...